Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer

por Huang Bartlett, Cynthia, Mardekian, Jack, Cotter, Matthew James, Huang, Xin, Zhang, Zhe, Parrinello, Christina M., Bourla, Ariel Bulua
Publicado 2020